1. Home
  2. MRBK vs ALEC Comparison

MRBK vs ALEC Comparison

Compare MRBK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$20.17

Market Cap

222.3M

Sector

Finance

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$2.47

Market Cap

262.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
ALEC
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.3M
262.7M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
MRBK
ALEC
Price
$20.17
$2.47
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$20.00
$4.83
AVG Volume (30 Days)
119.3K
609.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.77%
N/A
EPS Growth
30.34
N/A
EPS
1.89
N/A
Revenue
$6,316,000.00
$21,045,000.00
Revenue This Year
$25.40
$18.36
Revenue Next Year
$8.15
N/A
P/E Ratio
$10.68
N/A
Revenue Growth
10.13
N/A
52 Week Low
$11.17
$0.98
52 Week High
$21.59
$3.40

Technical Indicators

Market Signals
Indicator
MRBK
ALEC
Relative Strength Index (RSI) 60.93 54.35
Support Level $18.32 $1.89
Resistance Level $20.86 $2.57
Average True Range (ATR) 0.54 0.19
MACD 0.03 0.01
Stochastic Oscillator 51.25 55.38

Price Performance

Historical Comparison
MRBK
ALEC

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: